UA29421C2 - Спосіб виділення фактора vііі з інших білків в плазмі крові - Google Patents

Спосіб виділення фактора vііі з інших білків в плазмі крові

Info

Publication number
UA29421C2
UA29421C2 UA94020494A UA94020494A UA29421C2 UA 29421 C2 UA29421 C2 UA 29421C2 UA 94020494 A UA94020494 A UA 94020494A UA 94020494 A UA94020494 A UA 94020494A UA 29421 C2 UA29421 C2 UA 29421C2
Authority
UA
Ukraine
Prior art keywords
proteins
blood plasma
factor viii
isolating
isolating factor
Prior art date
Application number
UA94020494A
Other languages
English (en)
Russian (ru)
Inventor
Пер КЕРСГААРД
Original Assignee
Ново-Нордіск А/с
Ново-Нордиск А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ново-Нордіск А/с, Ново-Нордиск А/С filed Critical Ново-Нордіск А/с
Publication of UA29421C2 publication Critical patent/UA29421C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

Винахід стосуєься способу виділення біологічних сполук з рідких складових організму з використанням гель-фільтрації на першій стадії виділення. Спосіб полягає в тому, що виділена плазма або разморожена свіжозаморожена плазма крові піддається груповому розділенню способом гель-фільтрації при використанні великого навантаження і високої швидкості потоку.
UA94020494A 1989-11-09 1990-11-05 Спосіб виділення фактора vііі з інших білків в плазмі крові UA29421C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK562189A DK162233C (da) 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
PCT/DK1990/000279 WO1991007438A1 (en) 1989-11-09 1990-11-05 A method for isolating factor viii

Publications (1)

Publication Number Publication Date
UA29421C2 true UA29421C2 (uk) 2000-11-15

Family

ID=8144000

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94020494A UA29421C2 (uk) 1989-11-09 1990-11-05 Спосіб виділення фактора vііі з інших білків в плазмі крові

Country Status (26)

Country Link
US (1) US5245014A (uk)
EP (1) EP0524172B1 (uk)
JP (1) JP2509407B2 (uk)
CN (1) CN1044121C (uk)
AT (1) ATE118508T1 (uk)
AU (1) AU631471B2 (uk)
BG (1) BG61231B1 (uk)
CA (1) CA2073012C (uk)
CZ (1) CZ537190A3 (uk)
DE (1) DE69017050T2 (uk)
DK (1) DK162233C (uk)
ES (1) ES2068404T3 (uk)
FI (1) FI103510B (uk)
HU (1) HU214905B (uk)
IE (1) IE66836B1 (uk)
IL (1) IL96277A (uk)
NO (1) NO180741C (uk)
NZ (1) NZ236004A (uk)
PL (1) PL164894B1 (uk)
PT (1) PT95830B (uk)
RU (1) RU2055593C1 (uk)
SK (1) SK537190A3 (uk)
UA (1) UA29421C2 (uk)
WO (1) WO1991007438A1 (uk)
YU (1) YU47524B (uk)
ZA (1) ZA908599B (uk)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042138T3 (es) * 1989-05-24 1993-12-01 Miles Inc. Filtracion en gel del factor viii tratado termicamente.
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
US6180371B1 (en) 1996-06-26 2001-01-30 Emory University Modified factor VIII
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US7560107B2 (en) 1996-06-26 2009-07-14 Emory University Modified factor VIII
US6458563B1 (en) 1996-06-26 2002-10-01 Emory University Modified factor VIII
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
US6290527B1 (en) * 1998-07-03 2001-09-18 Nippon Telegraph And Telephone Corp. Nippon telegraph and telephone corporation
PT2130554E (pt) 1999-02-22 2012-11-19 Univ Connecticut Formulações de factor viii isentas de albumina
JP2002348300A (ja) * 1999-04-12 2002-12-04 Fujimori Kogyo Co Ltd 血液凝固第ｖｉｉｉ因子および血液凝固第ｖｉｉｉ因子／フォン・ビルブラント因子複合体の精製方法
AUPR638801A0 (en) * 2001-07-13 2001-08-09 Life Therapeutics Limited Factor viii separation
ES2449044T3 (es) 2004-05-03 2014-03-18 Emory University Procedimiento de administración de fVIII sin dominio B porcino
US20080176789A1 (en) * 2004-08-27 2008-07-24 Novc Nordisk Healthcare A/G Purification of Factor Xlll Polypeptides From Biological Materials
US20060226086A1 (en) * 2005-04-08 2006-10-12 Robinson Thomas C Centrifuge for blood processing systems
US20100168018A1 (en) * 2008-11-07 2010-07-01 Baxter International Inc. Factor viii formulations
ES2610529T3 (es) * 2010-03-30 2017-04-28 Octapharma Ag Un procedimiento de purificación de proteínas dependientes de vitamina K, tales como el factor de coagulación IX
RU2445974C2 (ru) * 2010-04-26 2012-03-27 Учреждение Российской академии медицинских наук Гематологический научный центр ГНЦ РАМН Способ получения концентрата фактора viii из плазмы крови человека
SG190136A1 (en) 2010-11-05 2013-07-31 Baxter Int A new variant of antihemophilic factor viii having increased specific activity
SG191186A1 (en) 2010-12-15 2013-07-31 Baxter Int Eluate collection using conductivity gradient
CN103506080A (zh) * 2012-06-19 2014-01-15 汪志友 一种用于分离纯化凝血因子viii的介质及其制备方法
MX358997B (es) * 2012-09-28 2018-09-12 Chugai Pharmaceutical Co Ltd Metodo para evaluar la reaccion de coagulacion sanguinea.
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
US4675385A (en) * 1985-03-27 1987-06-23 Alpha Therapeutic Corporation Isolation of human plasma procoagulant protein factor VIII from biological factors
US4758657A (en) * 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
ATE112287T1 (de) * 1987-12-21 1994-10-15 Miles Inc Faktor viii- gelfiltration.
WO1989009784A1 (en) * 1988-04-08 1989-10-19 Commonwealth Serum Laboratories Commission Production of heat-stable factor viii concentrate
ES2042138T3 (es) * 1989-05-24 1993-12-01 Miles Inc. Filtracion en gel del factor viii tratado termicamente.

Also Published As

Publication number Publication date
ES2068404T3 (es) 1995-04-16
RU2055593C1 (ru) 1996-03-10
PT95830A (pt) 1991-09-30
BG61231B1 (en) 1997-03-31
US5245014A (en) 1993-09-14
YU210590A (sh) 1993-05-28
CA2073012A1 (en) 1991-05-10
NO180741C (no) 1997-06-11
CN1051732A (zh) 1991-05-29
AU631471B2 (en) 1992-11-26
NO180741B (no) 1997-03-03
EP0524172B1 (en) 1995-02-15
FI103510B1 (fi) 1999-07-15
AU6747090A (en) 1991-06-13
HU214905B (hu) 1998-07-28
CA2073012C (en) 1996-03-19
CZ537190A3 (cs) 1998-05-13
PL287703A1 (en) 1991-12-02
NO921839D0 (no) 1992-05-08
ATE118508T1 (de) 1995-03-15
PL164894B1 (pl) 1994-10-31
IE904022A1 (en) 1991-05-22
IL96277A (en) 1995-07-31
NO921839L (no) 1992-07-08
JPH05501557A (ja) 1993-03-25
DK162233B (da) 1991-09-30
HUT60511A (en) 1992-09-28
DE69017050D1 (de) 1995-03-23
FI922105A (fi) 1992-05-08
CN1044121C (zh) 1999-07-14
DK562189A (da) 1991-05-10
IL96277A0 (en) 1991-08-16
IE66836B1 (en) 1996-02-07
YU47524B (sh) 1995-10-03
EP0524172A1 (en) 1993-01-27
DK562189D0 (da) 1989-11-09
NZ236004A (en) 1991-11-26
FI922105A0 (fi) 1992-05-08
WO1991007438A1 (en) 1991-05-30
JP2509407B2 (ja) 1996-06-19
HU9201551D0 (en) 1992-08-28
PT95830B (pt) 1997-11-28
DK162233C (da) 1992-03-16
FI103510B (fi) 1999-07-15
SK278640B6 (en) 1997-12-10
DE69017050T2 (de) 1995-06-14
ZA908599B (en) 1991-07-31
SK537190A3 (en) 1997-12-10

Similar Documents

Publication Publication Date Title
UA29421C2 (uk) Спосіб виділення фактора vііі з інших білків в плазмі крові
Saklatvala et al. Purification to homogeneity of pig leucocyte catabolin, a protein that causes cartilage resorption in vitro
ZA88268B (en) Seal arrangement for fluid filters;and method
AU600997B2 (en) Method of isolating and purifying nucleic acids from biological samples
AU5378686A (en) Process for the extraction and purification of proteins from culture media producing them
IE892983L (en) Mammalian t-cell growth factor
EP0194502A3 (en) Means and method for the separation of plasma or serum from whole blood
GB8903271D0 (en) Enzymatic membrane method for the synthesis and separation of peptides
IL90190A0 (en) Vector for secretion of proteins directly into periplasm or culture medium and method for synthesizing pure proteins utilizing the same
CA2130280A1 (en) Method for Purification of Cardiac Troponin I
AU6256990A (en) Anticoagulant and antihelminthic proteins and methods for the production and use of the same
US4681844A (en) Process for producing an Interleukin-1 preparation
Robinson et al. Partial characterization of in vivo chemotactic activity: comparison to human C5a
DE3361689D1 (en) Process for the separation and purification of proteases and antiproteases of blood coagulation and of the protease-antiprotease complex
US4808533A (en) Method of preventing T-cell blastogenesis
LV10690B (en) Method for separation of blood proteins
CS390888A1 (en) Method of purified allergens preparation from materials of biological origin
Bezdenezhnykh et al. Important shifts in urbanization and population migration in the European Socialist countries
GEP19960051B (en) Method for Isolation of Biologically Active Plant Peptides
PL248497A1 (en) Method for multi-stage oxydation of cyclohexane in liquid phase
PL248529A1 (en) Method for multistage oxydation of cyclohexane in liquid phase
UA5743C2 (uk) Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання
AU603794C (en) Affinity chromatography method for the separation and purification of protein antigens of the bacteria of the bordetella genus
AU671301C (en) Adsorbent for cellular fibronectin, separation and purification of fibronectin, and purification of blood
UA10328A (uk) Спосіб імуhостимуляції